Tiggeler R G, Berden J H, Hoitsma A J, Koene R A
Ann Surg. 1985 Feb;201(2):246-51. doi: 10.1097/00000658-198502000-00020.
Recent studies have indicated that maximal hydration of the transplant recipient can substantially reduce the incidence of acute tubular necrosis (ATN). However, this policy requires invasive hemodynamic monitoring, prolonged mechanical ventilation, and bears the risk of overhydration. In a prospective trial we studied the incidence of ATN in recipients of cadaveric kidneys after restricted fluid infusion (Group 1, N = 21), after restricted fluid infusion along with 250 ml of mannitol 20% (Group 2, N = 19), and after a moderate hydration policy together with 250 ml mannitol 20% (Group 3; N = 21). Donor- and preoperative recipient parameters were comparable in all three groups. The total amount of fluid administered and the incidence of ATN were as follows: Group 1-1059 +/- 371 ml and 43%; Group 2-1548 +/- 622 ml and 53%; and Group 3-2529 +/- 675 ml and 4.8%. The moderate hydration policy in Group 3 resulted in a significantly higher peroperative systolic blood pressure compared to Groups 1 and 2. We did not observe any problems related to overhydration. The reduction of ATN incidence led to a substantial decrease in the number of hemodialysis treatments, radionuclide scans, ultrasound investigations, transplant biopsies, and rejection episodes in the first 3 months after transplantation. It is concluded that moderate fluid administration of 2.5 liters during the transplant procedure together with infusion of 250 ml of mannitol 20% immediately before vessel clamp release reduces the incidence of postoperative ATN below five per cent. The procedure is safe, simple, and does not require invasive hemodynamic monitoring.
近期研究表明,使移植受者充分水化可显著降低急性肾小管坏死(ATN)的发生率。然而,该策略需要有创血流动力学监测、延长机械通气时间,且存在水化过度的风险。在一项前瞻性试验中,我们研究了在尸体肾移植受者中,限制液体输注(第1组,N = 21)、限制液体输注并同时给予250毫升20%甘露醇(第2组,N = 19)以及适度水化策略并同时给予250毫升20%甘露醇(第3组,N = 21)后ATN的发生率。三组的供体和术前受者参数具有可比性。给予的液体总量及ATN发生率如下:第1组为1059±371毫升,发生率为43%;第2组为1548±622毫升,发生率为53%;第3组为2529±675毫升,发生率为4.8%。与第1组和第2组相比,第3组的适度水化策略导致术中收缩压显著更高。我们未观察到与水化过度相关的任何问题。ATN发生率的降低导致移植后前3个月血液透析治疗、放射性核素扫描、超声检查、移植肾活检及排斥反应发作的次数大幅减少。得出的结论是,在移植过程中适度给予2.5升液体,并在血管夹松开前立即输注250毫升20%甘露醇,可将术后ATN的发生率降低至5%以下。该方法安全、简单,且无需有创血流动力学监测。